Cavabio Consulting LLC’s Post

Here are some practical pointers for Medical Affairs and Product Development professionals.

A recent survey from McKinsey & Co. reveals a growing consumer preference for products backed by clinical evidence. At curalife, we're staying ahead of the curve by investing in two double-blind clinical trials for our flagship product, Curalin. We're committed to delivering the science-backed benefits our customers deserve. Do you want to know more about Curalin's innovative clinical trials? Contact us! #ClinicalTrials #ScienceBacked #Curalin

🌟 Shoutout to the Trailblazers in Pharmacy! 🌟 At PlexusDx, we're in awe of the incredible work pharmacists in the PGx consulting business are doing. These professionals are not just fulfilling their roles; they are redefining them. By practicing at the top of their license, they embody what it truly means to be an innovator in healthcare. These visionary pharmacists are staunch advocates for the benefits of precision medicine. Their dedication to patient care is not just commendable – it's transformative. They're not just following trends; they're setting them by ensuring each patient receives personalized care based on their unique genetic makeup. This is the future of healthcare, and they are leading the charge! 📢 If you're not already following these forward thinkers, now is the time. Their insights and contributions are making an undeniable impact in our industry. By following them, you'll be at the forefront of the latest developments in precision medicine and patient care. Let's give a round of applause for these innovators who are shaping the future of pharmacy and healthcare! 👏 🔗 Follow these change-makers to stay updated on how they're advancing the field of PGx consulting. Kate Shaw Sue Paul Dan Krinsky, BS, MS, RPh, FAPhA Amanda Ward 🚀 Janet Reese, PharmD Chana Hershkop #PrecisionMedicine #PharmacyInnovation #PGx #pharmacogenomics #HealthcareHeroes #PlexusDx

For anyone interested in pharmaceutical industry data exchange standards, CDISC, clinical ontologies or semantic mapping, I'd highly recommend ClinLine's free Break and Learn webinars. In today's session, Berber Snoeijer took us through biomedical term collections like SNOWMED, LOINC, OMOP and others and talked a bit about some cases of mapping from one to another. I think this discussion area is interesting for a couple of reasons. In early drug discovery activities, I've seen good work from people who standardised fields from heterogenous data sets with OMOP terms to support large-scale analyses. If comparing like with like is important for your work, this kind of semantic mapping can help. One of my current interests is to see how well ICD 10 <--> MedDRA code mappings work. I see that there's already a project that maps ICD-10 to MedDRA. This seems like it would be useful in making it easier to identify records from routinely collected health data (e.g. England's HES data sets) that might describe things of interest like adverse events. I'll also be trying to read more on how well MedDRA codes might map to the NHS's OPCS-4 codes. Thanks for a great seminar Berber! https://lnkd.in/etSDC9sV #cdisc #sdtm #semanticmapping #loinc #snowmed #omop

Excited to share our thoughts on AI and its potential in Specialty Pharmacy. Check out our insights and join the conversation!

💰 Edwards Lifesciences to acquire Innovalve Bio Medical Ltd. Combined with Edwards Lifesciences’ existing mitral innovations, the acquisition enhances the company’s TMVR technologies to address large unmet structural heart patient needs and support sustainable long-term growth. Innovalve Bio Medical Ltd. will join the transcatheter mitral and tricuspid therapies (TMTT) product group, led by corporate vice president, Daveen Chopra. Edwards Lifesciences is developing a portfolio of transcatheter repair and replacement therapies designed to address mitral and tricuspid valve diseases. Read more online: https://lnkd.in/geN-TSZc 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

Our journey began to find a way for the early diagnosis of colorectal cancer. That drive led us to develop not just solutions for ourselves, but two groundbreaking platforms—AiGenX™ and MetaGenX™—that are transforming the field of drug discovery. These platforms now enable us to move forward with even greater confidence, while also providing researchers, startups, and pharmaceutical innovators the tools to accelerate their own studies and clinical trials. Through data-driven insights, we're not only continuing our fight against colorectal cancer but helping others fast-track their breakthroughs. Join us as we revolutionise medicine discovery with our cutting-edge technologies! #DrugDiscovery #AI #ClinicalTrials #Innovation #PrecisionMedicine #AiGenX #MetaGenX

Introducing Roselin Medical's AiGenX™ and MetaGenX™ platforms—tailored solutions for accelerating drug discovery and clinical trials. AiGenX™ empowers researchers by generating privacy-preserving synthetic datasets for AI model training, particularly in rare disease research. MetaGenX™ simulates drug interactions, optimising treatment strategies and predicting patient-specific responses to therapies. These tools streamline the drug development process, reduce costs, and boost success rates. Want to learn more? Watch our YouTube introduction and discover how we can drive your next breakthrough! https://lnkd.in/edcn-PAS #Pharmaceuticals #DrugDiscovery #ClinicalTrials #PrecisionMedicine #SyntheticData

Unlocking the power of Real-World Evidence (RWE) 🔓 The NEST Mark initiative which is being developed by the National Evaluation System for health Technology Coordinating Center (NESTcc) has succeeded in empowering another efficient and streamlined path to FDA clearance. The NEST Mark process is revolutionizing the use of real-world data and evidence in medical technology development. By guiding the design and execution of fit-for-purpose studies, NEST is setting the highest standards for RWE application. Intuitive's recent labeling modification success exemplifies the power of NEST Mark, showcasing the immense potential of RWE in premarket product development. Looking to learn more about RWE and NEST Mark? Join us at #APF2024 to hear from NEST and FDA leadership on how this innovative collaboration is advancing medical device evaluation and expediting #patientaccess. Join us at APF: mdic.org/APF Read more about the latest NEST Mark approval: https://lnkd.in/efD8yimn

Hello, #NOLA! Catch our SinguLab® team at PointClickCare SUMMIT booth S3.6! We're excited to share information about our partnership with #PCC and how we bring personalized medicine programs to long-term and post-acute care. Just look for the orange shoes, you'll know when you find us! #precisionmedicine #pharmacogenomics #pgx #precisiondosing